Medical News Today -- An article published Online First and in an upcoming edition of The Lancet reports that new research based on a meta-analysis of thirteen statin trials has shown that use of statins increases the risk of developing type 2 diabetes by 9 percent. Still, the absolute risk is low, especially when compared with the beneficial effect that statins have on reducing coronary events. The article is the work of Professor Naveed Satar and Dr David Preiss, Glasgow Cardiovascular Research Centre, University of Glasgow, UK, and colleagues.
